Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2007. Start Trial.
Date Value
December 31, 2025 12.32M
June 30, 2025 11.17M
December 31, 2024 10.37M
June 30, 2024 11.35M
December 31, 2023 9.767M
June 30, 2023 7.304M
December 31, 2022 5.907M
June 30, 2022 5.864M
December 31, 2021 6.482M
June 30, 2021 6.819M
December 31, 2020 7.395M
June 30, 2020 5.804M
December 31, 2019 5.299M
June 30, 2019 5.363M
December 31, 2018 5.606M
June 30, 2018 4.058M
December 31, 2017 2.528M
June 30, 2017 2.989M
December 31, 2016 4.158M
Date Value
June 30, 2016 5.417M
December 31, 2015 4.219M
June 30, 2015 2.423M
December 31, 2014 2.61M
June 30, 2014 3.428M
December 31, 2013 3.256M
June 30, 2013 0.3006M
December 31, 2012 -0.425M
June 30, 2012 0.7185M
December 31, 2011 -0.9398M
June 30, 2011 -3.832M
December 31, 2010 -4.361M
June 30, 2010 -3.573M
December 31, 2009 -1.975M
June 30, 2009 0.6022M
December 31, 2008 -0.1041M
June 30, 2008 0.1193M
December 31, 2007 1.116M
June 30, 2007 1.075M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Smith & Nephew plc 849.38M
NexGel, Inc. -3.338M
AstraZeneca PLC 8.051B
GSK Plc 6.621B
IDEXX Laboratories, Inc. 1.233B